Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
16,964,108
-
Shares change
-
-1,416,125
-
Total reported value, excl. options
-
$1,105,536,697
-
Value change
-
-$93,370,525
-
Put/Call ratio
-
2.34%
-
Number of buys
-
56
-
Number of sells
-
-73
-
Price
-
$65.14
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q3 2021
170 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q3 2021.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,964,108 shares
of 834,731,296 outstanding shares and own 2.03% of the company stock.
Largest 10 shareholders include ROYAL BANK OF CANADA (3,357,367 shares), RENAISSANCE TECHNOLOGIES LLC (1,988,338 shares), BlackRock Inc. (1,364,395 shares), VANGUARD GROUP INC (1,148,428 shares), STATE STREET CORP (876,812 shares), BANK OF MONTREAL /CAN/ (693,918 shares), GOLDMAN SACHS GROUP INC (635,010 shares), DIMENSIONAL FUND ADVISORS LP (555,417 shares), MORGAN STANLEY (494,429 shares), and Nuveen Asset Management, LLC (392,979 shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.